Skip to main content
Log in

Autoimmune autonomic failure in a patient with myeloma-associated Shy-Drager syndrome

  • Research Paper
  • Published:
Clinical Autonomic Research Aims and scope Submit manuscript

Abstract

We report here the case of a patient with the Shy-Drager syndrome and multiple myeloma who had evidence consistent with a central neural autoimmune basis for sympathetic autonomic failure. Autonomic function testing showed no recordable peroneal skeletal muscle sympathoneural traffic, normal arterial norepinephrine (NE) spillover during supine rest and no increment in NE spillover during exposure to lower body negative pressure. The patient's cerebrospinal fluid and serum contained an immunoglobulin G that bound to rat locus ceruleus (LC) in an in vitro test system. The myeloma protein was of the λ subtype and bound in the rat LC, without binding in the substantia nigra, as demonstrated with anti-λ antiserum. Since in this case the monoclonal antibody produced by the myeloma bound specifically to LC cells, the results are consistent with the hypothesis that in this patient the Shy-Drager syndrome may have had an immune-mediated basis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Goldstein DS, Polinsky RJ, Garty M et al. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension.Ann Neurol 1989;26: 558–563.

    Google Scholar 

  2. Ziegler MG, Lake CR, Kopin IJ. The sympathetic-nervous-system defect in primary orthostatic hypotension.N Engl J Med 1977;296: 293–297.

    Google Scholar 

  3. Murphy W, Mann R, McGrath BP, Bell C. Neuronal antibodies and autonomic failure [letter].Lancet 1993;342: 563.

    Google Scholar 

  4. Polinsky RJ, McRae A, Baser SM, Dahlstrom A. Antibody in the CSF of patients with multiple system atrophy reacts specifically with rat locus ceruleus.J Neurol Sci 1991;106: 96–104.

    Google Scholar 

  5. Angeletti PU, Levi-Montalcini R. Growth inhibition of sympathetic cells by some adrenergic blocking agents (6-hydroxydopaminemice and rats-immunosympathectomy-chemical sympathectomysuperior cervical ganglion).Proc Natl Acad Sci USA 1972;69: 86–88.

    Google Scholar 

  6. Grossman E, Rea RF, Hoffman A, Goldstein DS. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers.Am J Physiol 1991;260: R142-R147.

    Google Scholar 

  7. Goldstein DS, Eisenhofer G, Garty M, Sax FL, Keiser HR, Kopin IJ. Pharmacologic and tracer methods to study sympathetic function in primary hypertension.Clin Exp Hypertens 1989;A11 (Suppl. 1): 173–189.

    Google Scholar 

  8. Grossman E, Chang PC, Hoffman A, Tamrat M, Kopin IJ, Goldstein DS. Tracer norepinephrine kinetics: dependence on regional blood flow and the site of infusion.Am J Physiol 1991;260: R946-R952.

    Google Scholar 

  9. Grossman E, Rea RF, Hoffman A, Goldstein DS. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers.Am J Physiol 1991;260: R142-R147.

    Google Scholar 

  10. Holmes C, Eisenhofer G, Goldstein DS. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection.J Chromatogr B Biomed Appl 1994;653: 131–138.

    Google Scholar 

  11. Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin IJ. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.J Clin Invest 1988;81: 213–220.

    Google Scholar 

  12. Dalakas MC, Illa I, Dambrosia JM et al. A controlled trial of highdose intravenous immune globulin infusions as treatment for dermatomyositis.N Engl J Med 1993;329: 1993–2000.

    Google Scholar 

  13. Goldstein DS, Grossman E, Listwak S, Folio CJ. Sympathetic reactivity during a yohimbine challenge test in essential hypertension.Hypertension 1991;18 (Suppl. III): III-40–III-48.

    Google Scholar 

  14. Shu SY, Ju G, Fan LZ. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system.Neurosci Lett 1988;85: 169–171.

    Google Scholar 

  15. Meredith IT, Eisenhofer G, Lambert GW, Jennings GL, Thompson J, Esler MD. Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure.Hypertension 1992;19: 628–633.

    Google Scholar 

  16. Biaggioni I, Robertson RM, Robertson D. Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure.J Clin Pharmacol 1994;34: 418–423.

    Google Scholar 

  17. Robertson D, Goldberg MR, Tung CS, Hollister AS, Robertson RM. Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system.J Clin Invest 1986;78: 576–581.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. S. Goldstein MD PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldstein, D.S., McRae, A., Holmes, C. et al. Autoimmune autonomic failure in a patient with myeloma-associated Shy-Drager syndrome. Clinical Autonomic Research 6, 17–21 (1996). https://doi.org/10.1007/BF02291401

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02291401

Keywords

Navigation